ATE504836T1 - Verfahren zur identifizierung von trpv2- modulatoren - Google Patents
Verfahren zur identifizierung von trpv2- modulatorenInfo
- Publication number
- ATE504836T1 ATE504836T1 AT06836632T AT06836632T ATE504836T1 AT E504836 T1 ATE504836 T1 AT E504836T1 AT 06836632 T AT06836632 T AT 06836632T AT 06836632 T AT06836632 T AT 06836632T AT E504836 T1 ATE504836 T1 AT E504836T1
- Authority
- AT
- Austria
- Prior art keywords
- trpv2
- identifying
- modulators
- discovery
- discovered
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73168605P | 2005-10-31 | 2005-10-31 | |
| US78265606P | 2006-03-15 | 2006-03-15 | |
| PCT/US2006/042241 WO2007053526A1 (en) | 2005-10-31 | 2006-10-30 | Compositions and methods for identifying modulators of trpv2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE504836T1 true ATE504836T1 (de) | 2011-04-15 |
Family
ID=37776906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06836632T ATE504836T1 (de) | 2005-10-31 | 2006-10-30 | Verfahren zur identifizierung von trpv2- modulatoren |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7575882B2 (de) |
| EP (1) | EP1952160B1 (de) |
| JP (1) | JP2009513159A (de) |
| CN (1) | CN101542288A (de) |
| AT (1) | ATE504836T1 (de) |
| AU (1) | AU2006308914A1 (de) |
| DE (1) | DE602006021223D1 (de) |
| WO (1) | WO2007053526A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007259745A (ja) * | 2006-03-28 | 2007-10-11 | Japan Health Science Foundation | Trpv2特異的アッセイ方法およびtrpv2特異的薬剤のスクリーニング方法 |
| WO2008109596A2 (en) * | 2007-03-07 | 2008-09-12 | Janssen Pharmaceutica N.V. | Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators |
| GB2448535A (en) * | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
| KR100951656B1 (ko) | 2008-02-25 | 2010-04-07 | 고려대학교 산학협력단 | 프로베네시드를 포함하는 trpv2 활성제 |
| JP5328190B2 (ja) * | 2008-03-24 | 2013-10-30 | 株式会社マンダム | Trpa1の活性化物質の評価方法 |
| CN102575997B (zh) | 2009-06-09 | 2014-12-17 | 生物传感器股份有限公司 | 血液代谢物水平的无创监测 |
| US20130203715A1 (en) * | 2010-07-20 | 2013-08-08 | Pulmatrix, Inc. | Use of trp channel agonists to treat infections |
| US20130316008A1 (en) * | 2010-08-05 | 2013-11-28 | Agency For Science, Technology And Research | Multicompartmentalized vesicular structure and a method for forming the same |
| JP5877204B2 (ja) | 2010-09-29 | 2016-03-02 | パルマトリックス,インコーポレイテッド | 吸入用の一価金属カチオン乾燥粉末 |
| CN102154494B (zh) * | 2011-03-14 | 2013-01-02 | 中国人民解放军军事医学科学院基础医学研究所 | 一种用于儿童哮喘检测的标志物 |
| WO2014165303A1 (en) | 2013-04-01 | 2014-10-09 | Pulmatrix, Inc. | Tiotropium dry powders |
| US10024845B2 (en) * | 2013-12-23 | 2018-07-17 | Basf Se | Methods for determining modulators of insect transient receptor potential V (TRPV) channel |
| JP2017521044A (ja) | 2014-04-22 | 2017-08-03 | キュー−ステート バイオサイエンシーズ, インコーポレイテッドQ−State Biosciences, Inc. | 疼痛及び感覚障害のための化合物の分析 |
| WO2016138383A1 (en) | 2015-02-27 | 2016-09-01 | The Feinstein Institute For Medical Research | Treatment method, compounds, and method of increasing trpv2 activity |
| US10048275B2 (en) | 2015-03-13 | 2018-08-14 | Q-State Biosciences, Inc. | Cardiotoxicity screening methods |
| JP2020520966A (ja) | 2017-05-22 | 2020-07-16 | ジービーエス グローバル バイオファーマ,インコーポレイテッド | Trpv1を標的にするミルセン及びカンナビノイド含有組成物 |
| AU2019272849A1 (en) | 2018-05-22 | 2021-01-14 | Gbs Global Biopharma, Inc. | Cannabinoids and/or terpenes for use in TRPV1 modulation |
| US10959961B2 (en) | 2018-12-14 | 2021-03-30 | Natural Extraction Systems, LLC | Methods of administering anionic cannabinoid molecules dissolved in water |
| US10609944B1 (en) | 2018-12-14 | 2020-04-07 | Natural Extraction Systems, LLC | Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
| BR112021011509A2 (pt) * | 2018-12-14 | 2021-08-31 | Natural Extraction Systems, LLC | Composições e métodos relativos a moléculas de canabinoide aniônicas |
| CA3130763A1 (en) | 2019-02-25 | 2020-09-03 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
| JP2022538864A (ja) * | 2019-06-28 | 2022-09-06 | ジービーエス グローバル バイオファーマ,インコーポレイテッド | Trpv1のアロステリックモジュレータを用いた疼痛の治療 |
| US20230003713A1 (en) * | 2019-12-02 | 2023-01-05 | CCG Holding, Inc. | Methods of screening compositions for cannabinoids |
| WO2022026960A1 (en) | 2020-07-31 | 2022-02-03 | Natural Extraction Systems, LLC | Compositions and methods related to excipients and cannabinoid formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037675A1 (en) * | 1998-01-22 | 1999-07-29 | The Regents Of The University Of California | Nucleic acid sequences encoding capsaicin receptors |
| GB9827016D0 (en) | 1998-12-08 | 1999-02-03 | Merck Sharp & Dohme | Receptor protein |
| CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
| US20070196866A1 (en) * | 2004-03-13 | 2007-08-23 | Irm Llc | Modulators of ion channel trpa1 |
| WO2006005471A1 (en) | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with vanilloid receptor 2 (vr2(vrl-1)) |
| WO2006116773A2 (en) | 2005-04-28 | 2006-11-02 | The Regents Of The University Of California | Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders |
-
2006
- 2006-10-30 JP JP2008538944A patent/JP2009513159A/ja not_active Withdrawn
- 2006-10-30 DE DE602006021223T patent/DE602006021223D1/de active Active
- 2006-10-30 EP EP06836632A patent/EP1952160B1/de not_active Not-in-force
- 2006-10-30 AU AU2006308914A patent/AU2006308914A1/en not_active Abandoned
- 2006-10-30 CN CNA2006800496068A patent/CN101542288A/zh active Pending
- 2006-10-30 AT AT06836632T patent/ATE504836T1/de not_active IP Right Cessation
- 2006-10-30 US US11/589,340 patent/US7575882B2/en active Active
- 2006-10-30 WO PCT/US2006/042241 patent/WO2007053526A1/en not_active Ceased
-
2009
- 2009-07-09 US US12/499,891 patent/US20090275649A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7575882B2 (en) | 2009-08-18 |
| DE602006021223D1 (de) | 2011-05-19 |
| EP1952160B1 (de) | 2011-04-06 |
| US20070105086A1 (en) | 2007-05-10 |
| EP1952160A1 (de) | 2008-08-06 |
| WO2007053526A1 (en) | 2007-05-10 |
| JP2009513159A (ja) | 2009-04-02 |
| AU2006308914A1 (en) | 2007-05-10 |
| US20090275649A1 (en) | 2009-11-05 |
| CN101542288A (zh) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
| ATE514755T1 (de) | Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung | |
| ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
| ATE533502T1 (de) | Verfahren zur modulation der il-23-aktivität; relevante reagenzien | |
| TW200622950A (en) | Methods of monitoring the concentration of an analyte | |
| ATE513833T1 (de) | Thienopyridinverbindungen und verfahren zu ihrer verwendung | |
| EP1875693A4 (de) | Verfahren und systeme zur aufrechterhaltung des dienstqualitätsniveaus von datenübertragungen | |
| DE602005014134D1 (de) | Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten | |
| ATE424560T1 (de) | Marker für neuromyelitis optica | |
| ATE497492T1 (de) | Reinigung von montelukast | |
| ATE431426T1 (de) | Verfahren zur identifizierung von lrrk2 interagierenden molekülen und zur reinigung von lrrk2 | |
| WO2008118626A3 (en) | Inhibitors of jnk and methods for identifying inhibitors of jnk | |
| DE602005015174D1 (de) | Verfahren zur herstellung von montelukast-natrium | |
| ATE362530T1 (de) | Verfahren und vorrichtung zur reinigung von nukleinsäuren | |
| EA200970407A1 (ru) | Ингибиторы киназ mapk/erk | |
| DE112005001530T5 (de) | Verfahren zur Spektralidentifikation von Mikroorganismen | |
| MX2019012169A (es) | Ensayos para evaluar la actividad de moduladores de miembros de la familia de hidroxiesteroide (17-beta) deshidrogenasa (hsd17b). | |
| ATE494548T1 (de) | Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase | |
| ATE456666T1 (de) | Verfahren zur auswertung von ribonukleotidsequenzen | |
| DE602006010400D1 (de) | Olanzapin-analoga und verfahren zu ihrer verwendung | |
| WO2006053315A3 (en) | Methods and compositions for treating cellular proliferative diseases | |
| TW200716132A (en) | Novel chemical compounds | |
| WO2009001222A3 (en) | METHOD FOR SCREENING FOR SELECTIVE MODULATOR OF THE NF-ϰB PATHWAY ACTIVATION | |
| BRPI0612209B8 (pt) | método para preparar uma mídia de impressão e mídia de impressão | |
| WO2006017748A3 (en) | Materials and methods for identifying anti-schizophrenic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |